A rare presentation of pemphigoid gestationis in pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260904Keywords:
Pemphigoid gestationis, Autoimmune bullous disease, Pregnancy dermatoses, BP180, CorticosteroidsAbstract
Pemphigoid gestationis (PG) is a rare autoimmune bullous dermatosis that may arise or worsen during pregnancy due to dynamic immunological and hormonal changes. This report describes a case of a 36-year-old gravida three, para two woman who developed non-pruritic erythematosquamous lesions at six months of gestation, with no prior history of similar complaints. Clinical evaluation and dermatologic consultation supported the diagnosis of PG, and the patient responded well to topical corticosteroid therapy. Her antenatal course remained uncomplicated, and she delivered a healthy infant via elective caesarean section at 39 weeks. Postpartum recovery was favourable, with near-complete resolution of lesions by four months. This case highlights the importance of early recognition, individualized management, and multidisciplinary care in optimizing maternal and foetal outcomes. Regular counselling is essential to address the disease course, associated risks, and the potential for postpartum relapse or recurrence in subsequent pregnancies.
References
Huilaja L, Mäkikallio K, Tasanen K. Gestational pemphigoid. Orphanet J Rare Dis. 2014;9:1-8. DOI: https://doi.org/10.1186/s13023-014-0136-2
Semkova K, Black M. Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol. 2009;145(2):138-44. DOI: https://doi.org/10.1016/j.ejogrb.2009.05.012
Fainaru O, Mashiach R, Kupferminc M, Shenhav M, Pauzner D, Lessing JB. Pemphigus vulgaris in pregnancy: a case report and review of the literature. Hum Reprod. 2000;15(5):126-30. DOI: https://doi.org/10.1093/humrep/15.5.1195
Marren P, Wojnarowska F, Venning V. Vulvar involvement in autoimmune bullous diseases. J Reprod Med. 1993;38:101-7.
Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 2: Diagnosis and therapy. J Dtsch Dermatol Ges. 2011;9(11):927-47. DOI: https://doi.org/10.1111/j.1610-0387.2011.07809.x
Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381:320-32. DOI: https://doi.org/10.1016/S0140-6736(12)61140-4
Tindall JG, Rea TH, Shulman I. Herpes gestationis in association with a hydatidiform mole: immunopathologic studies. Arch Dermatol. 1981;117:510-2. DOI: https://doi.org/10.1001/archderm.1981.01650080064032
Djahansouzi S, Nestle-Kraemling C, Dall P. Herpes gestationis may present as a paraneoplastic syndrome of choriocarcinoma: a case report. Gynecol Oncol. 2003;89:334-37. DOI: https://doi.org/10.1016/S0090-8258(03)00070-2
Shornick JK, Black MM. Secondary autoimmune diseases in herpes gestationis (pemphigoid gestationis). J Am Acad Dermatol. 1992;26:563-6. DOI: https://doi.org/10.1016/0190-9622(92)70081-P
Patel F, Wilken R, Patel FB. Pathophysiology of autoimmune bullous diseases: nature versus nurture. Indian J Dermatol. 2017;62(3):262-7. DOI: https://doi.org/10.4103/0019-5154.159620
Borthwick GM, Sunderland CA, Holmes RC, Black MM, Stirrat GM. Abnormal expression of HLA-DR antigen in the placenta of a patient with pemphigoid gestationis. J Reprod Immunol. 1984;6:393-6. DOI: https://doi.org/10.1016/0165-0378(84)90048-2
Powell AM, Sakuma-Oyama Y, Oyama N, Black MM. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Clin Exp Dermatol. 2005;30(6):682-7. DOI: https://doi.org/10.1111/j.1365-2230.2005.01937.x
Roth MM. Pregnancy dermatoses: diagnosis, management, and controversies. Am J Clin Dermatol. 2011;12:25-41. DOI: https://doi.org/10.2165/11532010-000000000-00000
Chi CC, Wang SH, Charles-Holmes R, Ambros-Rudolph C, Powell J, Jenkins R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol. 2009;160(6):1222-8. DOI: https://doi.org/10.1111/j.1365-2133.2009.09086.x
Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol. 2014;70(3):401.e1-401.14. DOI: https://doi.org/10.1016/j.jaad.2013.09.010
Shimanovich I, Bröcker EB, Zillikens D. Pemphigoid gestationis: new insights into the pathogenesis lead to novel diagnostic tools. BJOG. 2002;109(9):970-6. DOI: https://doi.org/10.1111/j.1471-0528.2002.01016.x
Bjarnason B, Flosadóttir E. Childhood, neonatal, and stillborn pemphigus vulgaris. Int J Dermatol. 1999;38(9):680-8. DOI: https://doi.org/10.1046/j.1365-4362.1999.00764.x
Genovese G, Derlino F, Cerri A, Moltrasio C, Muratori S, Berti E, Marzano AV. A systematic review of treatment options and clinical outcomes in pemphigoid gestationis. Front Med (Lausanne). 2020;7:604945. DOI: https://doi.org/10.3389/fmed.2020.604945
Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54(3):395-404. DOI: https://doi.org/10.1016/j.jaad.2005.12.012
Al-Saif F, Elisa A, Al-Homidy A, Al-Ageel A, Al-Mubarak M. Retrospective analysis of pemphigoid gestationis in 32 Saudi patients-clinicopathological features and a literature review. J Reprod Immunol. 2016;116:42-5. DOI: https://doi.org/10.1016/j.jri.2016.04.286
Intong LR, Murrell DF. Pemphigoid gestationis: pathogenesis and clinical features. Dermatol Clin. 2011;29(3):447-52. DOI: https://doi.org/10.1016/j.det.2011.03.002
Hallaji Z, Mortazavi H, Ashtari S, Nikoo A, Abdollahi M, Nasimia M. Pemphigoid gestationis: clinical and histologic features of twenty-three patients. Int J Womens Dermatol. 2017;3(2):86-90. DOI: https://doi.org/10.1016/j.ijwd.2016.11.004
Kushner CJ, Concha JSS, Werth VP. Treatment of autoimmune bullous disorders in pregnancy. Am J Clin Dermatol. 2018;19:391-403. DOI: https://doi.org/10.1007/s40257-018-0342-0
Downloads
Published
How to Cite
Issue
Section
